omarigliptin   Click here for help

GtoPdb Ligand ID: 8402

Synonyms: MK-3102 | MK3102
Compound class: Synthetic organic
Comment: Omarigliptin is an investigational long-acting inhibitor of dipeptidyl peptidase 4 (DPP4) [1]. The first DPP4 inhibitor to be clinically approved was sitagliptin. This has subsequently been joined by several more drugs such as vildagliptin, saxagliptin, linagliptin and alogliptin.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 98.83
Molecular weight 398.12
XLogP 0.93
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1ccc(c(c1)C1OCC(CC1N)N1Cc2c(C1)cn(n2)S(=O)(=O)C)F
Isomeric SMILES Fc1ccc(c(c1)[C@H]1OC[C@@H](C[C@@H]1N)N1Cc2c(C1)cn(n2)S(=O)(=O)C)F
InChI InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1
InChI Key MKMPWKUAHLTIBJ-ISTRZQFTSA-N
Bioactivity Comments
The pharmacokinetic profile of omarigliptin makes it suitable for once-weekly human dosing. Omarigliptin is more potent than sitagliptin, and is highly selective over all other proteases tested [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
dipeptidyl peptidase 4 Primary target of this compound Hs Inhibitor Inhibition 9.1 pKi - 1
pKi 9.1 (Ki 8x10-10 M) [1]